News

Harvard Management Co. disclosed a $2.2 billion stake in SpaceX, showing how the university's endowment has profited from an early bet on Elon Musk's giant rocket company. Janet Lorin, Bloomberg News Higher Education Reporter, discusses the disclosure and what it signals for other university investments.

Analog Devices (NASDAQ:ADI) reported fiscal third-quarter results that exceeded its outlook, with record revenue of $4.02 billion as growth accelerated across its industrial, automotive, communications and consumer markets. CEO and Chair Vincent Roche said the company’s first $4 billion quarter was

EL beats fiscal fourth-quarter estimates as sales rise 6%, fueled by Skin Care and Fragrance growth and sharply higher operating income.

Moderna and Merck are surging today after the two companies said their experimental mRNA-based treatment succeeded in a late-stage study of high-risk melanoma patients. The SPDR S&P Biotech ETF (XBI) jumped nearly 5%, while the NYSE Arca Pharmaceutical Index climbed over 3%. A positive clinical-trial result typically moves the companies developing the drug—and perhaps their closest competitors—not the entire healthcare sector.

Cogent Communications' 14% weekly rebound follows a narrower Q2 loss and margin gains, but revenue declines, Sprint runoff and debt risks keep the setup mixed.

Aug 19 (Reuters) - Indian fintech startup Navi said on Wednesday it will raise $100 million from Dutch technology investor Prosus NV in its first institutional funding round, a deal that comes ahead

Bitcoin broke out of a months long trading range, surging as much as 7.7%, amid optimism on the regulatory front with industry officials gathering at the White House.

On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock's biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.'s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. - Shares of Estee Lauder (EL) rallied after the beauty company's adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views. - Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker's forecast sales for the second quarter missed the average analyst estimate.

The Federal Reserve has not touched interest rates in over seven months, yet mortgage rates just climbed to their highest level in years. Understanding why exposes a flaw in how most borrowers think about the connection between the Fed and their monthly payment.

Target (TGT) lifted its full-year outlook on Wednesday as tariff refunds helped double the retailer'

Moderna shares more than doubled Wednesday after it announced initial results from a study of an experimental cancer treatment that would be the first of its kind if approved by regulators. Moderna and Merck are developing a treatment using an mRNA-based cancer vaccine called intismeran that is designed to be tailored to individual patients based on unique mutations within their tumors. In current studies, they are pairing it with Keytruda, a immunotherapy drug made by Merck.

Home improvement retailer Lowe's (LOW) released mixed second quarter results. Yahoo Finance Senior Reporter Brooke DiPalma comes on Market Catalysts to break down the areas where Lowe's is still seeing pressure on consumer spending and CEO Marvin Ellison's latest comments on the company's tariff refund.

Billionaire Ken Fisher’s eponymous firm appears to be betting that the longest-dated US bonds will rally, a contrarian stance that seeks to capitalize on yields close to their highest in two decades.

Alibaba is set to report its fiscal Q1 earnings on Aug. 20. Here’s how the data suggests BABA shares will respond to the earnings event.

While the top- and bottom-line numbers for Lowe's (LOW) give a sense of how the business performed in the quarter ended July 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Over the last six months, CooperCompanies’s shares have sunk to $75.74, producing a disappointing 9.5% loss - a stark contrast to the S&P 500’s 12.9% gain. This may have investors wondering how to approach the situation.

TGT tops Q2 estimates as traffic, digital and category sales strengthen, while tariff refunds lift profitability, and management raises its fiscal 2026 outlook.

TJX (TJX) issued a fiscal third-quarter comparable store sales forecast that fell short of Wall Stre

Here’s what could be next for Intel stock.

Comparable sales rose 3.8% on traffic growth, with EPS guidance lifted $0.75 excluding tariff refunds

Lowe's Companies (NYSE:LOW) reported second-quarter sales of $26 billion, up 8.3% from a year earlier, as growth in its professional customer, online and home-services businesses helped offset continued pressure on discretionary do-it-yourself spending. Comparable sales increased 0.2% in the quarte

Walmart is due to report earnings Thursday morning, with traders anticipating a big move from the retailer’s stock following the results.

Tesla Inc. CEO Elon Musk has backed the automaker’s domestic manufacturing prowess amid President Donald Trump‘s tariffs on the auto industry. Domestic Assembly, Domestic Parts On Saturday, podcast host Katie Miller took to the social media platform X, sharing a...

Target (TGT) is buzzing on Wednesday after the retail giant beat second quarter earnings estimates, topped off by a raise on full-year guidance. Yahoo Finance Senior Reporter Brooke DiPalma highlights the biggest takeaways from the company's earnings calls, underlining price discount drivers ahead of the back-to-school shopping season.

U.S. stocks are higher this morning after yesterday’s tech and bond selloff. The Nasdaq was up 0.2%, while the Dow Jones Industrial Average and S&P 500 rose 0.5%. Here's what is driving the markets today: Treasury buybacks: U.

DAN shares jump 10% as cost savings, stronger sales and higher 2026 forecasts outweigh a quarterly earnings miss and lower profit outlook.

Shoppers looking for the lowest prices may be paying more than they realize.

Eshallgo’s California subsidiary will exclusively distribute Zhongshan Senwei printing consumables in North America, initially targeting major e-commerce channels as the company builds its overseas operations. Key Investor TakeawaysEshallgo (NASDAQ:EHGO) has secured an exclusive North American distribution partnership with Chinese printing consumables manufacturer Zhongshan Senwei.

Target just posted its strongest quarter in years, but strip out a one-time government windfall and the story gets far more complicated. Here is what the headline numbers are hiding about whether this retailer's turnaround is built to last.

Estee Lauder Companies Inc (NYSE:EL, XETRA:ELAA) shares jumped more than 15% on Wednesday after the beauty group posted fourth-quarter results that beat Wall Street estimates and raised its profit margin outlook for fiscal 2027. The company reported revenue of $3.6 billion for its fiscal...